MedPath

Diabetes Reversal Online Program and Study (DROP Study)

Not Applicable
Recruiting
Conditions
Type 2 Diabetes
Interventions
Behavioral: plant-based diet
Registration Number
NCT05572502
Lead Sponsor
Physicians Committee for Responsible Medicine
Brief Summary

This is an interventional study that will evaluate the feasibility, implementation, and efficacy of an online, 12-week, plant-based, nutrition education program in a community setting. Data will also be analyzed to see if participation in the program results in reductions glycated hemoglobin levels, body weight, and cholesterol levels.

Detailed Description

This study aims to assess the feasibility and implementation of an online, plant-based, diabetes reversal program in a community setting. The study will also assess changes in glycated hemoglobin, body weight, and plasma lipids with an online 12-week, plant-based, nutrition education program. These health benefits may illustrate feasibility to physicians and healthcare professionals elsewhere, in addition to their value for the individual research participants.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • U.S. Men and women meeting the age of majority, defined as follows: Age 19 or older in Nebraska and Alabama; Age 21 or older in Mississippi; Age 18 or older in all other states
  • Prior diagnosis of type 2 diabetes mellitus
Exclusion Criteria
  • Use of recreational drugs in the past 6 months
  • Pregnancy or intention to become pregnant during the study period, as verified by self-report
  • Unstable medical or psychiatric illness
  • Lack of English fluency
  • Inability to maintain current medication regimen
  • Inability or unwillingness to participate in all components of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Vegan dietplant-based dietAll participants will follow a low-fat vegan diet. There are no other study arms or control group.
Primary Outcome Measures
NameTimeMethod
Glycated hemoglobin12 weeks

A1c will be measured before and after the study period

Secondary Outcome Measures
NameTimeMethod
body weight12 weeks

participants will track body weight weekly using a RNFO scale

total cholesterol12 weeks

total cholesterol will be measured before and after the study period

LDL cholesterol12 weeks

LDL cholesterol will be measured before and after the study period

medication usage12 weeks

changes in medications to treat diabetes will be tracked during the study period

Trial Locations

Locations (1)

Physician Committee for Responsible Medicine

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath